BGRSX
Price
$15.25
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
QLENX
Price
$15.78
Change
+$0.07 (+0.45%)
Updated
Sep 20 closing price
Ad is loading...

BGRSX vs QLENX

Header iconBGRSX vs QLENX Comparison
Open Charts BGRSX vs QLENXBanner chart's image
Boston Partners Global Long/Short I
Price$15.25
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
AQR Long-Short Equity N
Price$15.78
Change+$0.07 (+0.45%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BGRSX vs QLENX Comparison Chart
Loading...
VS
BGRSX vs. QLENX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGRSX is a Buy and QLENX is a Hold.

FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 1.96B vs. BGRSX (164M). QLENX pays higher dividends than BGRSX: QLENX (18.52) vs BGRSX (1.25). BGRSX was incepted earlier than QLENX: BGRSX (10 years) vs QLENX (11 years). BGRSX is a more actively managed with annual turnover of: 172.00 vs. QLENX (0.00). BGRSX (2500) and QLENX (2500) have matching initial minimum investment requirements. QLENX annual gain was more profitable for investors over the last year : 24.60 vs. BGRSX (14.67). QLENX return over 5 years is better than : 95.44 vs. BGRSX (59.93).
BGRSXQLENXBGRSX / QLENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years11 years-
Gain YTD10.62021.07350%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets164M1.96B8%
Annual Yield % from dividends1.2518.527%
Returns for 1 year14.6724.6060%
Returns for 3 years42.2189.7247%
Returns for 5 years59.9395.4463%
Returns for 10 years66.99121.9255%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMPL33.600.09
+0.27%
Simply Good Foods Company (The)
NOK4.19N/A
N/A
Nokia Corp
EPM5.61-0.12
-2.09%
Evolution Petroleum Corp
AYTU2.47-0.06
-2.37%
Aytu BioPharma
CTKB5.06-0.28
-5.24%
Cytek Biosciences